SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-015741
Filing Date
2024-06-06
Accepted
2024-06-06 16:15:47
Documents
1
Period of Report
2024-05-28

Document Format Files

Seq Description Document Type Size
1 form4-06062024_080643.html 4  
1 form4-06062024_080643.xml 4 4115
  Complete submission text file 0001415889-24-015741.txt   5565
Mailing Address C/O TETRAPHASE PHARMACEUTICALS, INC. 480 ARSENAL STREET, SUITE 110 WATERTOWN MA 02472
Business Address
Lubner David Charles (Reporting) CIK: 0001572000 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41259 | Film No.: 241025249

Mailing Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065 240-327-0603
Arcellx, Inc. (Issuer) CIK: 0001786205 (see all company filings)

IRS No.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)